A network meta-analysis of association between cardiometabolic risk factors and COVID-19 outcome severity.

Alina Binbin LiBo YangYufei LiRachel HuynhSamuel ShimKenneth LoJie LiAndrew ZulloWen-Chih WuSimin Liu

Published in: Journal of diabetes (2023)

Considering the high prevalence of cardiometabolic comorbidities and risk of all severe outcomes, patients with cardiometabolic comorbidities should be prioritized in vaccination and treatment development of COVID-19.

Keyphrases

coronavirus disease
sars cov
risk factors
respiratory syndrome coronavirus
type diabetes
metabolic syndrome
combination therapy
insulin resistance
replacement therapy